Guillain-Barré Syndrome and Johnson & Johnson Vaccine: What to Do

[ad_1]

Officials said the syndrome is usually reported about two weeks after vaccination, especially in men, most of whom are 50 years or older. In a statement made by the agency, it was stated that there is not enough evidence yet that the vaccine causes the disease, but the FDA will continue to monitor the situation.

The FDA said there is no data to suggest a link between the condition and Covid-19 vaccines made by Pfizer-BioNTech or Moderna, both based on a different technology.

The FDA states in its revised information sheet for patients that the syndrome is most likely to occur within 42 days of vaccination. You should consult a doctor if you begin to experience weakness or tingling in your arms and legs, double vision, or difficulty walking, speaking, chewing, swallowing, or controlling your bladder or bowels.

The condition is typically treated with either an infusion of antibodies. immunoglobulin therapyor plasma exchange, in which a patient’s blood plasma is removed and replaced.

After the acute phase has passed, many patients receive physical therapy or rehabilitation to rebuild their strength. While the process is slow, most people eventually make a full recovery. Some patients may experience prolonged fatigue, weakness or pain.

If the link between the vaccine and Guillain-Barré is real, it seems to far outweigh the risks of Covid-19, experts say. In a statement from the CDC, it was stated that almost all hospitalizations and deaths from Covid-19 in the United States occurred in unvaccinated people. The agency recommends that everyone 12 years of age or older get vaccinated.

Dr. “Everything has risks,” Salmon said. “And the key to decision making is to optimize the benefits and reduce the risks.” “Covid is a pretty nasty disease that has killed 600,000 people,” he added.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *